Liposome News and Research

Latest Liposome News and Research

Merck Serono, EMD Serono resume Stimuvax clinical program for NSCLC

Merck Serono, EMD Serono resume Stimuvax clinical program for NSCLC

Celator presents new data on CPX-351 liposome injection at European Hematology Association congress

Celator presents new data on CPX-351 liposome injection at European Hematology Association congress

Abstract on Phase I/II DIGNITY trial of ThermoDox in RCW Breast Cancer accepted at ASTRO 2010

Abstract on Phase I/II DIGNITY trial of ThermoDox in RCW Breast Cancer accepted at ASTRO 2010

Hana Biosciences reports complete data from Marqibo Phase 2 RALLY trial for relapsed/refractory adult ALL

Hana Biosciences reports complete data from Marqibo Phase 2 RALLY trial for relapsed/refractory adult ALL

Research findings open door to development of new therapies for lymphomas, leukemias

Research findings open door to development of new therapies for lymphomas, leukemias

YM BioSciences raises $3.2M through non-brokered private placement of common shares

YM BioSciences raises $3.2M through non-brokered private placement of common shares

Research finding may offer future alternative to antibiotics

Research finding may offer future alternative to antibiotics

YM BioSciences initiates enrollment in nimotuzumab trial in brain metastases from NSCLC

YM BioSciences initiates enrollment in nimotuzumab trial in brain metastases from NSCLC

USPTO issues composition of matter patent for Transave's ARIKACE

USPTO issues composition of matter patent for Transave's ARIKACE

DMC recommends Celsion to continue enrollment in ThermoDox clinical study for primary liver cancer

DMC recommends Celsion to continue enrollment in ThermoDox clinical study for primary liver cancer

Takeda enters co-promotion agreement with Janssen Pharma for VELCADE

Takeda enters co-promotion agreement with Janssen Pharma for VELCADE

NIST, UM researchers detail operation of liposome manufacturing technique

NIST, UM researchers detail operation of liposome manufacturing technique

Celsion reports $4.6 million net loss from operations for first-quarter 2010

Celsion reports $4.6 million net loss from operations for first-quarter 2010

YM Biosciences to sell maximum of 7,750,000 common shares through Controlled Equity Offering

YM Biosciences to sell maximum of 7,750,000 common shares through Controlled Equity Offering

Celator Pharmaceuticals presents data on CPX-351 Liposome Injection and HDPN formulation

Celator Pharmaceuticals presents data on CPX-351 Liposome Injection and HDPN formulation

Celsion's ThermoDox Phase I trial data presented at 9th IHPBA World Congress

Celsion's ThermoDox Phase I trial data presented at 9th IHPBA World Congress

NeoPharm commences enrollment in Phase II clinical trial of LE-DT for pancreatic cancer

NeoPharm commences enrollment in Phase II clinical trial of LE-DT for pancreatic cancer

Pivotal preclinical data of YM BioSciences' CYT387 JAK1/2 inhibitor pre-published in Blood

Pivotal preclinical data of YM BioSciences' CYT387 JAK1/2 inhibitor pre-published in Blood

Celsion announces presentation of long-term follow-up data from Phase I ThermoDox dose escalation trial

Celsion announces presentation of long-term follow-up data from Phase I ThermoDox dose escalation trial

Results of Phase I ThermoDox dose escalation trial to be discussed in a press conference

Results of Phase I ThermoDox dose escalation trial to be discussed in a press conference